by Louiza | Jun 4, 2024 | News
AMSTERDAM, The Netherlands June 4, 2024 Biotech Newswire Annogen, a company with expertise in bespoke promoter design and gene expression engineering, today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the...
by Louiza | Dec 1, 2023 | News
Updates – December 2023 Annogen has signed a deal with an undisclosed gene therapy company for an AAV capsid screening project. For this project, Annogen will deliver its SuRE™ barcoding platform and downstream bioinformatics analysis to track...
by Louiza | Oct 1, 2023 | News
Updates – October 2023 Annogen is excited to share our latest break through in cellular engineering. We’ve successfully combined our SuRE™ promoter screening platform and our AIM™ integration site screening platform to establish HEK293 clones with...
by Louiza | Mar 1, 2023 | News
News – March 2023 AIM™ service (Annogen Integration Mapping: integration sites and their expression levels) was introduced in 2022 supporting cell engineering for cell therapy development. Now it is also available to the contract manufacturing market: manufacturing...
by Louiza | Jan 26, 2023 | News
PRESS RELEASE Annogen, The Netherlands, 26 January 2023 — the Amsterdam based biotech company behind the SuRE™ technology for the functional annotation of the non-coding part of the genome, started a collaboration with another top agricultural science and...
